ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Overview Fund Activity
Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

70 hedge funds and large institutions have $278M invested in Adamas Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-8
Holders Change %
-10.26%
% of All Funds
1.75%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
24
Reduced
22
Closed
10
Calls
$226K
Puts
$634K
Net Calls
-$408K
Net Calls Change
-$690K

Top Buyers

1
BlackRock
1
BlackRock
New York
$22.8M
2
AC
2
Armistice Capital
New York
$15.1M
3
PVI
3
Pura Vida Investments
New York
$4.16M
4
State of Wisconsin Investment Board
4
State of Wisconsin Investment Board
Wisconsin
$1.75M
5
PPA
5
Parametric Portfolio Associates
Washington
$1.96M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$43.1M
2
NC
2
Nexthera Capital
New York
$0
3
TCM
3
Tekla Capital Management
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$915K
5
Millennium Management
5
Millennium Management
New York
$7.75M
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
76
SG Americas Securities
New York
– -$143K -8,445 Closed
UBS Group
77
UBS Group
Switzerland
– -$26K -1,536 Closed
TRCT
78
Tower Research Capital (TRC)
New York
– -$18K -1,061 Closed
Creative Planning
79
Creative Planning
Kansas
– -$3K -200 Closed
1 2 3
4